- ►bmj.com [PDF] C Myra, L Sloper, PJ Tighe, RS McIntosh, SE … - British Medical Journal, 2004 - bjo.bmj.com If you have a burning desire to respond to a paper published in BJO, why not
make use of our ''rapid response'' option? Log onto our website
(www.bjophthalmol. com), find the paper that interests you, and send your ... Cited by 10 - Related articles - All 9 versions
G Mossetti, D Rendina, FG Numis, P Somma, L … - Clinical and experimental rheumatology, 2003 - 万方数据资源系统 Erdheim-Chester disease (ECD) is a rare non-Langherans form of histiocytosis
characterized radiologically by symmetrical sclerosis of the metaphysis and the
diaphysis of long tubular bones. Macrophages are potent interleukin-6 ... Cited by 12 - Related articles - BL Direct - All 3 versions
N Boissel, B Wechsler, V Leblond - Annals of Internal Medicine, 2001 - Am Coll Physicians Letters commenting on an Annals article will be considered if they are received
within 6 weeks of the time the article was published. Only some of the letters
received can be published. Published letters are edited and may be ... Cited by 13 - Related articles - All 2 versions
TG Sheidow, DA Nicolle, JG Heathcote - Eye (London, England), 2000 - ncbi.nlm.nih.gov Erdheim-Chester disease (ECD) is an increasingly recognised form of
fibro-inflammatory process characterised by xanthomatous histiocytes containing
large amounts of ingested lipid, plasma cells, macrophages and Touton-type ... Cited by 27 - Related articles - BL Direct - All 2 versions
MC Jendro, H Zeidler, H Rosenthal, H Haller, … - Clinical rheumatology, 2004 - Springer Received: 2 May 2003 / Accepted: 30 June 2003 / Published online: 7 November
2003 Ó Clinical Rheumatology 2003 Abstract Erdheim–Chester disease (ECD) is a
rare non-LangerhansÕ form of histiocytosis with a plethora of different ... Cited by 15 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org - Free from Publisher F Braiteh, C Boxrud, B Esmaeli, R Kurzrock - Blood, 2005 - bloodjournal.hematologylibrary.org Erdheim-Chester disease is a rare non-Langerhans histiocytosis with multisystem
involvement. To date, there is no standard treatment for this disorder, and more
than half of the patients succumb within 3 years. Because interferon- ... Cited by 30 - Related articles - BL Direct - All 4 versions
AM Nasr, T Johnson, A Hidayat - Orbit, 1991 - informahealthcare.com Juvenile xanthogranuloma (JXG) is a benign histiocytic inflammatory condition
often re- ferred to as nevoxanthoendothelioma. The dis- ease is thoroughly
described in the dermatologic literature, with the skin and the eye being ... Cited by 6 - Related articles - All 3 versions
ZA Karcioglu, N Sharara, TL Boles, AM Nasr - Ophthalmic Plastic & Reconstructive Surgery, 2003 - journals.lww.com Skip Navigation Links Home > September 2003 - Volume 19 - Issue 5 > Orbital
Xanthogranuloma: Clinical and Morphologic Features i... ... *Tulane University
Health Sciences Center, Departments of Ophthalmology and Pathology, New ... Cited by 9 - Related articles - BL Direct - All 4 versions
D Ivan, A Neto, L Lemos, A Gupta - Archives of Pathology and Laboratory Medicine, 2003 - arpa.allenpress.com Erdheim-Chester disease is a very rare xanthogranulomatous, non-Langerhans cell
systemic histiocytosis with an unknown etiology and pathogenesis.
Histologically, it is characterized by a diffuse infiltration with large, ... Cited by 9 - Related articles - All 2 versions
